Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials, 2015, Nashat Gabrail , Ronald Yanagihara , Marek Spaczyński , William Cooper , Erin O'Boyle , Carrie Smith , Ralph Boccia , Cancer Management and Research, 7, 83--92, ISSN: 1179-1322, bibliogr. tab. summ.
Słowa kluczowe: cancer, chemotherapy-induced nausea and vomiting, subcutaneous
Kod: CZR-ZAG BibTeX (pkt. 5)